IBDEI0C2 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5721,1,2,0)
 ;;=2^99243
 ;;^UTILITY(U,$J,358.3,5722,0)
 ;;=99244^^47^510^4
 ;;^UTILITY(U,$J,358.3,5722,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5722,1,1,0)
 ;;=1^Comprehensive, Moderate
 ;;^UTILITY(U,$J,358.3,5722,1,2,0)
 ;;=2^99244
 ;;^UTILITY(U,$J,358.3,5723,0)
 ;;=99245^^47^510^5
 ;;^UTILITY(U,$J,358.3,5723,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5723,1,1,0)
 ;;=1^Comprehensive, High
 ;;^UTILITY(U,$J,358.3,5723,1,2,0)
 ;;=2^99245
 ;;^UTILITY(U,$J,358.3,5724,0)
 ;;=60100^^48^511^1^^^^1
 ;;^UTILITY(U,$J,358.3,5724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5724,1,2,0)
 ;;=2^BIOPSY OF THYROID
 ;;^UTILITY(U,$J,358.3,5724,1,4,0)
 ;;=4^60100
 ;;^UTILITY(U,$J,358.3,5725,0)
 ;;=20220^^48^511^2^^^^1
 ;;^UTILITY(U,$J,358.3,5725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5725,1,2,0)
 ;;=2^BONE BIOPSY TROCAR/NEEDLE
 ;;^UTILITY(U,$J,358.3,5725,1,4,0)
 ;;=4^20220
 ;;^UTILITY(U,$J,358.3,5726,0)
 ;;=10021^^48^511^3^^^^1
 ;;^UTILITY(U,$J,358.3,5726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5726,1,2,0)
 ;;=2^FNA W/O IMAGE
 ;;^UTILITY(U,$J,358.3,5726,1,4,0)
 ;;=4^10021
 ;;^UTILITY(U,$J,358.3,5727,0)
 ;;=10022^^48^511^4^^^^1
 ;;^UTILITY(U,$J,358.3,5727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5727,1,2,0)
 ;;=2^FNA W/IMAGE
 ;;^UTILITY(U,$J,358.3,5727,1,4,0)
 ;;=4^10022
 ;;^UTILITY(U,$J,358.3,5728,0)
 ;;=96372^^48^512^1^^^^1
 ;;^UTILITY(U,$J,358.3,5728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5728,1,2,0)
 ;;=2^THER/PROPH/DIAG INJ SC/IM
 ;;^UTILITY(U,$J,358.3,5728,1,4,0)
 ;;=4^96372
 ;;^UTILITY(U,$J,358.3,5729,0)
 ;;=99071^^48^513^3^^^^1
 ;;^UTILITY(U,$J,358.3,5729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5729,1,2,0)
 ;;=2^PATIENT EDUCATION MATERIALS
 ;;^UTILITY(U,$J,358.3,5729,1,4,0)
 ;;=4^99071
 ;;^UTILITY(U,$J,358.3,5730,0)
 ;;=99078^^48^513^2^^^^1
 ;;^UTILITY(U,$J,358.3,5730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5730,1,2,0)
 ;;=2^GROUP HEALTH EDUCATION
 ;;^UTILITY(U,$J,358.3,5730,1,4,0)
 ;;=4^99078
 ;;^UTILITY(U,$J,358.3,5731,0)
 ;;=99354^^48^513^4^^^^1
 ;;^UTILITY(U,$J,358.3,5731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5731,1,2,0)
 ;;=2^PROLONGED OTPT SVC > 30 MIN
 ;;^UTILITY(U,$J,358.3,5731,1,4,0)
 ;;=4^99354
 ;;^UTILITY(U,$J,358.3,5732,0)
 ;;=99355^^48^513^5^^^^1
 ;;^UTILITY(U,$J,358.3,5732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5732,1,2,0)
 ;;=2^PROLONG OTPT SVC,EA ADDL 30 MIN
 ;;^UTILITY(U,$J,358.3,5732,1,4,0)
 ;;=4^99355
 ;;^UTILITY(U,$J,358.3,5733,0)
 ;;=99090^^48^513^1^^^^1
 ;;^UTILITY(U,$J,358.3,5733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5733,1,2,0)
 ;;=2^COMPUTER DATA ANALYSIS
 ;;^UTILITY(U,$J,358.3,5733,1,4,0)
 ;;=4^99090
 ;;^UTILITY(U,$J,358.3,5734,0)
 ;;=607.84^^49^514^1
 ;;^UTILITY(U,$J,358.3,5734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5734,1,4,0)
 ;;=4^IMPOTENCE
 ;;^UTILITY(U,$J,358.3,5734,1,5,0)
 ;;=5^607.84
 ;;^UTILITY(U,$J,358.3,5734,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,5735,0)
 ;;=606.9^^49^514^3
 ;;^UTILITY(U,$J,358.3,5735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5735,1,4,0)
 ;;=4^MALE INFERTILITY NOS
 ;;^UTILITY(U,$J,358.3,5735,1,5,0)
 ;;=5^606.9
 ;;^UTILITY(U,$J,358.3,5735,2)
 ;;=^62833
 ;;^UTILITY(U,$J,358.3,5736,0)
 ;;=606.1^^49^514^4
 ;;^UTILITY(U,$J,358.3,5736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5736,1,4,0)
 ;;=4^OLIGOSPERMIA
 ;;^UTILITY(U,$J,358.3,5736,1,5,0)
 ;;=5^606.1
 ;;^UTILITY(U,$J,358.3,5736,2)
 ;;=^85449
 ;;^UTILITY(U,$J,358.3,5737,0)
 ;;=257.2^^49^514^5
 ;;^UTILITY(U,$J,358.3,5737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5737,1,4,0)
 ;;=4^TESTICULAR HYPOFUNC NEC
 ;;^UTILITY(U,$J,358.3,5737,1,5,0)
 ;;=5^257.2
